国家: 英国
语言: 英文
来源: MHRA (Medicines & Healthcare Products Regulatory Agency)
Paracetamol
Cipla EU Ltd
N02BE01
Paracetamol
500mg
Effervescent tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04070100; GTIN: 8901117079892 8901117238077
PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL 500 MG EFFERVESCENT TABLETS paracetamol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. FOR MEDICINE AVAILABLE WITHOUT A PRESCRIPTION: Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4 • You must contact a doctor if you do not feel better or if you feel worse after 3 days. FOR MEDICINE AVAILABLE ONLY ON PRESCRIPTION: • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS THIS LEAFLET: 1. What Paracetamol Effervescent Tablets is and what it is used for 2. What you need to know before you take Paracetamol Effervescent Tablets 3. How to take Paracetamol Effervescent Tablets 4. Possible side effects 5. How to store Paracetamol Effervescent Tablets 6. Contents of the pack and other information 1. WHAT PARACETAMOL EFFERVESCENT TABLETS IS AND WHAT IT IS USED FOR This medicine contain paracetamol, which belongs to a group of medicines called analgesics and antipyretics that relieve mild to moderate pain and/or fever. It can be used to relieve headache, migraine, neuralgia, toothache, period pain, rheumatic aches and pains, sore throat and the symptoms of colds and flu. You must talk to a doctor if you do not feel better or if you do not improve after 3 days 2. WHAT YOU NEED 阅读完整的文件
OBJECT 1 PARACETAMOL 500 MG EFFERVESCENT TABLETS Summary of Product Characteristics Updated 03-Oct-2022 | Cipla EU Ltd • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Paracetamol 500 mg effervescent tablets 2. Qualitative and quantitative composition Each effervescent tablet contains 500 mg of paracetamol. Excipients with known effects: Each effervescent tablet contains 439.46 mg of sodium Each effervescent tablet contains 20 mg of aspartame. For the full list of excipients see section 6.1. 3. Pharmaceutical form Effervescent tablet. White to off-white, circular, flat-faced, bevelled edge tablets debossed with a ring on one side and plain on the other. Diameter 25.2 mm. 4. Clinical particulars 4.1 Therapeutic indications Symptomatic treatment of mild to moderate pain and/or fever in adults and adolescents aged 12 years and above. 4.2 Posology and method of administration Posology _Paediatric population_ Dose depends on body weight and age. A single dose ranges from 10 to 阅读完整的文件